Filtros de búsqueda

Lista de obras de Vincenza Conteduca

(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.

artículo científico publicado en 2015

A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma

artículo científico publicado en 2020

AR copy number and AR signaling-directed therapies in castration-resistant prostate cancer.

artículo científico publicado en 2017

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

scientific article published on 19 March 2019

Activity of new agents (NAs) as third-line treatment in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) after a long-term disease control (LTDC) with abiraterone acetate (AA) or enzalutamide (ENZ) post docetaxel (DOC): Prelimin

Activity of new agents (NAs) as third-line treatment in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) showing a primary resistance (PRes) to NAs-based second line therapy after docetaxel (DOC): Preliminary results from a mult

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

artículo científico publicado en 2017

Androgen receptor signaling pathways as a target for breast cancer treatment

artículo científico publicado en 2016

Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer

artículo científico publicado en 2016

Association among metabolic syndrome, inflammation, and survival in prostate cancer

scientific article published on 02 March 2018

Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.

artículo científico publicado en 2016

B-cell frequency in hepatitis C virus-related mixed cryoglobulinemia.

artículo científico publicado en 2013

BRCA2-Associated Prostate Cancer in a Patient With Spinal and Bulbar Muscular Atrophy

artículo científico publicado en 2018

Barrett's esophagus and esophageal cancer: an overview.

artículo científico publicado en 2012

Biological Evolution of Castration-resistant Prostate Cancer

scientific article published on 14 February 2019

CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone.

artículo científico publicado en 2016

Cell-free DNA as a diagnostic marker for cancer: current insights

artículo científico publicado en 2016

Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide

artículo científico publicado en 2014

Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone

artículo científico publicado en 2014

Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer.

artículo científico publicado en 2016

Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer

artículo científico publicado en 2017

Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.

artículo científico publicado en 2015

Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test

scientific article published on 09 November 2018

Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer

artículo científico publicado en 2020

Circulating tumor cells: utopia or reality?

artículo científico publicado en 2013

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.

artículo científico publicado en 2014

Clinical features of neuroendocrine prostate cancer

artículo científico publicado en 2019

Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancer

scientific article published on 24 October 2014

Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus.

artículo científico publicado en 2016

Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer

artículo científico publicado en 2019

Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis

artículo científico publicado en 2019

Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone

artículo científico publicado en 2014

Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program

article

Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer

artículo científico publicado en 2020

Erratum to: 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide

artículo científico publicado en 2015

Genome-wide plasma DNA methylation features of metastatic prostate cancer

artículo científico publicado en 2020

H. pylori infection and gastric cancer: state of the art (review).

artículo científico publicado en 2012

Hepatitis C virus infection and mixed cryoglobulinemia

artículo científico publicado en 2012

High Neutrophil-to-lymphocyte Ratio Persistent During First-line Chemotherapy Predicts Poor Clinical Outcome in Patients with Advanced Urothelial Cancer

artículo científico publicado en 2014

Identification of single nucleotide variants using position-specific error estimation in deep sequencing data

Identification of single nucleotide variants using position-specific error estimation in deep sequencing data

scientific article published on 02 August 2019

Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy

artículo científico publicado en 2020

Immunotherapy for Prostate Cancer: Where We Are Headed

artículo científico publicado en 2017

Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists

scientific article published on 01 October 2020

Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.

artículo científico publicado en 2015

Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study.

artículo científico publicado en 2013

Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.

artículo científico publicado en 2015

In reply

artículo científico publicado en 2012

Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis

artículo científico publicado en 2008

Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis

artículo científico publicado en 2013

Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?

artículo científico publicado en 2018

Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.

artículo científico publicado en 2017

Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinib.

artículo científico publicado en 2013

Metabolic syndrome as a peculiar target for management of prostate cancer patients

artículo científico

Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone.

artículo científico publicado en 2015

Molecular mechanisms of resistance in testicular germ cell tumors - Clinical implications

artículo científico publicado en 2018

N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer

artículo científico publicado en 2019

Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies

artículo científico publicado en 2014

Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer

artículo científico publicado en 2018

PSA flare with abiraterone in patients with metastatic castration-resistant prostate cancer

artículo científico publicado en 2014

Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.

artículo científico publicado en 2010

Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer.

artículo científico publicado en 2016

Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma.

artículo científico publicado en 2016

Plasma AR Copy Number Changes and Outcome to Abiraterone and Enzalutamide

artículo científico publicado en 2020

Plasma AR and abiraterone-resistant prostate cancer.

artículo científico publicado en 2015

Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer

artículo científico publicado en 2019

Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis

scientific article published on 24 September 2019

Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer

artículo científico publicado en 2018

Plasma Androgen Receptor in Prostate Cancer

artículo científico publicado en 2019

Plasma androgen receptor and serum chromogranin A in advanced prostate cancer

artículo científico publicado en 2018

Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer

artículo científico publicado en 2020

Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors

artículo científico publicado en 2020

Precancerous colorectal lesions (Review).

artículo científico

Prognostic role of circulating tumor cells-CTCs in metastatic renal cell carcinoma

Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

artículo científico publicado en 2017

Psychosocial Issues in Long-Term Survivors of Testicular Cancer

Re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:6

artículo científico publicado en 2017

Re: Niven Mehra, David Dolling, Semini Sumanasuriya, et al. Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA). Eur Urol 2018;74:2

artículo científico publicado en 2018

Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 201

artículo científico publicado en 2016

Reply to the letter to the editor 'Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer' by Yang et al

artículo científico publicado en 2018

Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review

artículo científico publicado en 2016

Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage

artículo científico publicado en 2009

SLFN11 expression in advanced prostate cancer and response to platinum-based chemotherapy

scientific article published on 03 March 2020

Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme

artículo científico publicado en 2015

Safety and clinical outcome of a cohort of patients (pts) with castration resistant prostate cancer (CRPC) treated with abiraterone acetate (AA) in a named patient program (NPP): Updated results of a retrospective study from an Italian cooperative gr

article

Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme

article

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

artículo científico publicado en 2019

Serum and Plasma Copy Number Detection Using Real-time PCR.

artículo científico publicado en 2017

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.

artículo científico publicado en 2016

Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

artículo científico publicado en 2016

T cell receptor variable β gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.

artículo científico publicado en 2013

Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment

artículo científico publicado en 2020

Taxane-related nail toxicity.

artículo científico publicado en 2015

Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer

artículo científico publicado en 2021

Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide

scientific article published on 01 August 2019

The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment

scientific article published on 04 December 2019

The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy.

artículo científico

The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives

artículo científico publicado en 2020

The emerging role of anti-angiogenic therapy in ovarian cancer (review).

artículo científico publicado en 2014

The potential use of urine cell free DNA as a marker for cancer.

artículo científico publicado en 2016

Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.

artículo científico

Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.

artículo científico publicado en 2012

Urinary RNA-based biomarkers for prostate cancer detection.

artículo científico publicado en 2017

Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.

artículo científico publicado en 2016

Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review ⬇️

artículo científico

Vitamin D status among long-term survivors of testicular cancer

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda